Fundz

Who to call at Bioventus Inc., and when

Fundz watches for the moments Bioventus Inc. starts buying, and tells you who to reach.

  • An alert the day Bioventus Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bioventus Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bioventus Inc.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Bioventus Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

www.bioventus.com
Filed: Nov 17, 2025CIK: 0001665988Medical Device
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Bioventus appointed Ajay Dhankhar, PhD, Chief Corporate Development & Strategy Officer of Smith & Nephew plc, as a Class II director effective November 14, 2025, for a term ending at the 2026 annual meeting. He is Smith & Nephew's second board designee under the Stockholders Agreement, and he will not receive director compensation from the Company.

Key Takeaways

Ajay Dhankhar, PhD, joined the Bioventus Board as a Class II director effective November 14, 2025, serving until the 2026 annual meeting of stockholders or until a successor is duly selected and quali

Dhankhar is Smith & Nephew's second designee under the Stockholders Agreement dated February 16, 2021 (as amended), joining existing designee Philip G. Cowdy.

3 more takeaways

Related Filings (3)

3 more filings from Bioventus Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 17, 2025
Item5.02
CategoryExecutive Change
CIK0001665988
Accession #0001665988-25-000032
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
board change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Bioventus Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.